or
Bookmark and Share
Human voltage gated sodium channel .beta.1A subunit and methods of use
   
Document Number
US Patent 7063953
Issued Date
June 20, 2006
Link
Inventors
Qin; Ning (Blue Bell, PA)
Codd; Ellen (Blue Bell, PA)
Map
Abstract
DNAs encoding human voltage gated sodium channel .beta.1A subunit have been cloned and characterized. The recombinant protein is capable of forming biologically active protein. The cDNA's have been expressed in recombinant host cells that produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
3
Comments:
no comments yet
Owner
Published
June 20, 2006
Application Number
10/401,916
Filed
March 28, 2003
US Classification
435/7.21   436/501
Int'l Classification
G01N   33/567   (20060101)  
Examiner
Attorney/Law Firm
Parent Case
This case is a divisional application of U.S. patent application Ser. No. 09/875,456 filed Jun. 6, 2001 and entitled "The Human Voltage Gated Sodium Channel .beta.1A Subunit and Method of Use" which claims priority from U.S. Provisional Patent Application No. 60/294,405 filed Jun. 7, 2000 and entitled "DNA Encoding Human Voltage Gated Sodium Channel .beta.1A Subunit" and U.S. Provisional Patent Application No. 60/236,664 filed Sep. 29, 2000 also entitled "DNA Encoding Human Voltage Gated Sodium Channel .beta.1A Subunit" the contents of which are all hereby incorporated by reference in their entirety.
USPTO Field of Search
435/7.21   436/501  
Related Patents
7211407 - High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins - Owned by Chan Test, Inc. (Cleveland, OH)

Disclosed are high throughput assay systems and methods for identifying agents that alter the level of surface expression of integral membrane proteins, such as cardiac ion channels, in mammalian cells. Also disclosed are therapeutic methods of using agents identified using such methods.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us